Press Releases
Select a Month...
-
Standing Together Against Hate
3.19.21
A letter from Seattle Children’s Leadership team addressing increasing acts of violence, xenophobia and hate against Asian and Pacific Islander communities,...
-
Seattle Children’s announces Andrew Lee as Vice President and Chief Equity, Diversity and Inclusion Officer to lead system-wide anti-racism and organizational change efforts
2.8.21
Today, following a national search, Seattle Children’s announced Andrew Lee will join the organization as Vice President and Chief Equity, Diversity and...
-
A message from Dr. Jeff Sperring
2.3.21
It has been our deeply held value and commitment at Seattle Children’s to provide a place where every child and family member feels valued, safe and seen and...
-
Seattle Children’s Assessment Committee Work is Underway; Committee Provides Process for Sharing Information
1.30.21
Statement from The Seattle Children’s Assessment Committee
-
Former U.S. Attorney General Eric Holder of Covington & Burling to lead examination of institutional racism, equity, inclusion, and diversity practices at Seattle Children’s
1.14.21
New community and board trustee members named to Assessment Committee
-
Seattle Children’s Commits to Rigorous Review of Race, Equity and Inclusion Practices
1.6.21
New board committee formed, will include community members and independent outside expert
-
Seattle Children’s Plans COVID-19 Vaccine Rollout
12.15.20
Today, Seattle Children’s received its first doses of Pfizer’s COVID-19 vaccine and will deploy its allocation in phases based on guidelines from the Centers...
-
Statement from Seattle Children’s on Main Campus Operating Rooms
9.24.20
We frequently test the air in every OR and can confirm the operating rooms at Seattle Children’s are safe.
-
GentiBio launches to develop engineered regulatory T cells for autoimmune and inflammatory diseases
8.5.20
Announces exclusive licensing partnerships for proprietary regulatory T cell engineering technologies with Seattle Children's Research Institute, Benaroya...
-
CSL Behring and Seattle Children’s Research Institute to Advance Gene Therapy Treatments for Primary Immunodeficiency Diseases
6.2.20
Initially, the alliance will develop treatment options for patients with two rare, life-threatening primary immunodeficiency diseases – Wiskott-Aldrich...
